These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24166410)

  • 1. HPA axis genetic variation, cortisol and psychosis in major depression.
    Schatzberg AF; Keller J; Tennakoon L; Lembke A; Williams G; Kraemer FB; Sarginson JE; Lazzeroni LC; Murphy GM
    Mol Psychiatry; 2014 Feb; 19(2):220-7. PubMed ID: 24166410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
    Keller J; Gomez R; Williams G; Lembke A; Lazzeroni L; Murphy GM; Schatzberg AF
    Mol Psychiatry; 2017 Apr; 22(4):527-536. PubMed ID: 27528460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A; Gomez R; Tenakoon L; Keller J; Cohen G; Williams GH; Kraemer FB; Schatzberg AF
    Psychoneuroendocrinology; 2013 Jan; 38(1):115-21. PubMed ID: 22727477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.
    Schatzberg AF
    World J Biol Psychiatry; 2015 Jan; 16(1):2-11. PubMed ID: 24933348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition.
    Cherian K; Schatzberg AF; Keller J
    Schizophr Res; 2019 Nov; 213():72-79. PubMed ID: 31307859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of cortisol levels and genetic polymorphisms to antidepressant response to placebo and fluoxetine in patients with major depressive disorder: a prospective study.
    Ventura-Juncá R; Symon A; López P; Fiedler JL; Rojas G; Heskia C; Lara P; Marín F; Guajardo V; Araya AV; Sasso J; Herrera L
    BMC Psychiatry; 2014 Aug; 14():220. PubMed ID: 25086452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol circadian rhythm alterations in psychotic major depression.
    Keller J; Flores B; Gomez RG; Solvason HB; Kenna H; Williams GH; Schatzberg AF
    Biol Psychiatry; 2006 Aug; 60(3):275-81. PubMed ID: 16458262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.
    Posener JA; DeBattista C; Williams GH; Chmura Kraemer H; Kalehzan BM; Schatzberg AF
    Arch Gen Psychiatry; 2000 Aug; 57(8):755-60. PubMed ID: 10920463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of HPA axis related genes in men with hypersexual disorder.
    Jokinen J; Boström AE; Chatzittofis A; Ciuculete DM; Öberg KG; Flanagan JN; Arver S; Schiöth HB
    Psychoneuroendocrinology; 2017 Jun; 80():67-73. PubMed ID: 28319850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPA-axis multilocus genetic variation moderates associations between environmental stress and depressive symptoms among adolescents.
    Starr LR; Huang M
    Dev Psychopathol; 2019 Oct; 31(4):1339-1352. PubMed ID: 30394263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK; Twardowska K
    J Psychiatr Res; 1999; 33(5):363-70. PubMed ID: 10504004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing hormone system polymorphisms are associated with children's cortisol reactivity.
    Sheikh HI; Kryski KR; Smith HJ; Hayden EP; Singh SM
    Neuroscience; 2013 Jan; 229():1-11. PubMed ID: 23131710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPA axis multilocus genetic profile score moderates the impact of interpersonal stress on prospective increases in depressive symptoms for offspring of depressed mothers.
    Feurer C; McGeary JE; Knopik VS; Brick LA; Palmer RH; Gibb BE
    J Abnorm Psychol; 2017 Nov; 126(8):1017-1028. PubMed ID: 29154563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder.
    Ferrer A; Costas J; Labad J; Salvat-Pujol N; Segalàs C; Urretavizcaya M; Real E; de Arriba-Arnau A; Alonso P; Crespo JM; Barrachina M; Soriano-Mas C; Carracedo Á; Menchón JM; Soria V
    J Psychiatr Res; 2018 Sep; 104():227-234. PubMed ID: 30107269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis genetic variation and early stress moderates amygdala function.
    Di Iorio CR; Carey CE; Michalski LJ; Corral-Frias NS; Conley ED; Hariri AR; Bogdan R
    Psychoneuroendocrinology; 2017 Jun; 80():170-178. PubMed ID: 28364727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.
    Tyrka AR; Price LH; Gelernter J; Schepker C; Anderson GM; Carpenter LL
    Biol Psychiatry; 2009 Oct; 66(7):681-5. PubMed ID: 19596121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.